Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -9.49%10.99B | -12.89%12.14B | -21.38%2.5B | -10.93%2.92B | -20.67%3.46B | 4.60%3.26B | -14.69%13.94B | -27.03%3.18B | -12.77%3.27B | -0.31%4.36B |
| Cost of revenue | -10.74%7.92B | -18.13%8.87B | -21.35%1.92B | -16.28%2.13B | -26.19%2.48B | -6.03%2.35B | -12.12%10.83B | -27.51%2.44B | -15.01%2.55B | 4.55%3.35B |
| Gross profit | -6.11%3.07B | 5.34%3.27B | -21.47%587.4M | 7.72%785.22M | -2.32%985.17M | 47.14%917.13M | -22.59%3.11B | -25.42%747.99M | -3.90%728.97M | -13.64%1.01B |
| Operating expense | -5.43%3.57B | -5.49%3.77B | 5.60%1.08B | 5.25%959.33M | -8.10%878.53M | -22.53%849.56M | -8.32%3.99B | 9.24%1.03B | -16.69%911.51M | -16.38%956M |
| Operating profit | 0.95%-491.49M | 43.71%-496.18M | -78.38%-496.28M | 4.62%-174.12M | 102.91%106.64M | 114.28%67.57M | -161.98%-881.52M | -538.26%-278.21M | 45.59%-182.54M | 113.27%52.56M |
| Net non-operating interest income (expenses) | 42.38%-7.1M | 73.96%-12.33M | 87.89%-1.54M | 83.67%-2.1M | 84.00%-1.87M | 32.29%-6.82M | -4.41%-47.35M | -25.22%-12.74M | -20.44%-12.84M | -10.39%-11.7M |
| Non-operating interest income | 36.93%3.45M | -23.00%2.52M | 14.00%855K | -334.72%-1.7M | 177.54%2.71M | -20.44%654K | -18.19%3.27M | -16.11%750K | -16.71%723K | 0.31%975K |
| Non-operating interest expense | -28.93%10.55M | -70.67%14.85M | -82.23%2.4M | -97.06%399K | -63.87%4.58M | -31.40%7.47M | 2.58%50.62M | 21.89%13.49M | 17.64%13.56M | 9.54%12.67M |
| Net investment income | 49.47M | |||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | -12.87M | ||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -102.26%-88.97M | 561.92%3.93B | 66.11%-285.7M | 144.33%4.7M | -654.91%-12.68M | 93,034.00%4.22B | -7,761.29%-850.79M | -24,084.04%-843.04M | 11.64%-10.6M | -365.66%-1.68M |
| Less:Restructuring and mergern&acquisition | ---- | --0 | --0 | ---- | ---- | ---- | --245.43M | --233.55M | ---- | ---- |
| Less:Other special charges | 98.77%-51.3M | -5,995.79%-4.17B | 171.30%45.83M | -268.05%-4.7M | 654.91%12.68M | -93,034.00%-4.22B | -515.98%-68.41M | -1,728.51%-64.27M | -110.64%-1.28M | 365.66%1.68M |
| Less:Write off | -41.52%140.27M | -64.40%239.87M | ---- | ---- | ---- | ---- | --673.76M | ---- | ---- | ---- |
| Other non-operating income (expenses) | 2,607.82%58.71M | -107.50%-2.34M | -31.77%-14.82M | -40.95%4.78M | -72.37%10.97M | 38.95%-3.27M | 165.99%31.2M | -361.63%-11.25M | 143.08%8.09M | 1,075.28%39.7M |
| Income before tax | -114.02%-479.38M | 294.12%3.42B | 31.07%-798.35M | 15.75%-166.73M | 30.65%103.07M | 984.14%4.28B | -390.62%-1.76B | -1,994.89%-1.16B | 44.23%-197.89M | 336.90%78.89M |
| Income tax | -96.04%51.38M | 406.82%1.3B | 77.31%-98.17M | -7,457.98%-19.42M | 622.00%48.27M | 40,153.87%1.37B | -645.45%-422.82M | -309.56%-432.65M | 99.70%-257K | -70.63%6.69M |
| Net income | -125.01%-530.77M | 258.52%2.12B | 3.49%-700.18M | 25.46%-147.31M | -24.10%54.8M | 697.71%2.91B | -206.63%-1.34B | -399.14%-725.47M | 26.59%-197.63M | 1,633.26%72.2M |
| Net income continuous operations | -125.01%-530.77M | 258.52%2.12B | 3.49%-700.17M | 25.46%-147.31M | -24.10%54.8M | 697.71%2.91B | -206.63%-1.34B | -399.15%-725.47M | 26.59%-197.63M | 1,633.60%72.2M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -125.01%-530.77M | 258.52%2.12B | 3.49%-700.18M | 25.46%-147.31M | -24.10%54.8M | 697.71%2.91B | -206.63%-1.34B | -399.14%-725.47M | 26.59%-197.63M | 1,633.26%72.2M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -125.01%-530.77M | 258.52%2.12B | 3.49%-700.18M | 25.46%-147.31M | -24.10%54.8M | 697.71%2.91B | -206.63%-1.34B | -399.14%-725.47M | 26.59%-197.63M | 1,633.26%72.2M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -125.94%-130.13 | 258.17%501.61 | 4.71%-163.7 | 25.77%-34.76 | -25.15%12.83 | 694.24%687.24 | -205.55%-317.13 | -397.94%-171.79 | 26.89%-46.83 | 1,644.14%17.14 |
| Diluted earnings per share | -125.94%-130.13 | 258.17%501.61 | 0.53%-170.8732 | 25.84%-34.76 | -25.08%12.83 | 694.24%687.24 | -205.55%-317.13 | -397.94%-171.79 | 26.82%-46.8733 | 1,631.37%17.1241 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |